Overview
Specifications
Reagent | jetPEI® |
---|---|
Molecule delivered | DNA |
Applications | Plasmid transfection |
Cell types | Adherent and suspension cells |
Number of transfections | 1 ml of jetPEI® is sufficient to perform up to 2000 transfections in 96-well plates. |
Storage | Store jetPEI® at 5 °C ± 3°C. |
Provided with | 101-01N, 101-10N, 101-40N and 101B-010N are provided with 150 mM NaCl solution for complex formation |
Summary
jetPEI® transfection reagent is a linear polyethylenimine derivative, free of components of animal origin, providing highly effective and reproducible gene delivery to adherent and suspension cells. jetPEI® transfection reagent is therefore particularly well suited for automated or manual HTS (High Throughput Screening) with three protocols available: reverse, batch and forward.
Ordering information
Reference Number | Amount of reagent | Amount of NaCl |
---|---|---|
101000053 | jetPEI® 1 mL | 50 ml |
101000020 | jetPEI® 4 x 1 mL | 4 x 50 ml |
Description
3 protocols to suit your application
In the forward protocol, the cells are split the day before transfection and the jetPEI®/DNA complexes are added to the adherent or suspension cells.
The reverse protocol is the most appropriate when transfecting a pool of genes, such as a DNA library (Fig. 1). In this protocol, the jetPEI®/DNA complexes are prepared or deposited in the wells prior to addition of the cells. Complexes are stable for up to 4 hours (Fig. 2).
The batch protocol has been developed to prepare a homogeneous pool of transfected cells. For this purpose, the cells are transfected just after trypsinization, while still in suspension. This protocol is preferred for drug screening applications and allows rapid processing, one day faster than the forward protocol.
Fig. 1: jetPEI® reverse transfection protocol for HTS application.
Robust transfection complexes
Complexes formed with the water-soluble polymer jetPEI® and DNA allow efficient transfection for up to 4 hours, in contrast to lipid-based reagents and calcium phosphate. Thus they allow plenty of time to dispense the complexes into the plates (Fig. 2).
Fig. 2: Effect of complex formation incubation time on transfection efficiency with jetPEI®. HEK-293 cells were transfected in 96-well plates with pCMVLuc and jetPEI® following the reverse transfection protocol. Luciferase activity was measured after 24 h.
Batch to batch reproducibility
HTS DNA transfection using jetPEI® gives highly consistent transfection efficiency from batch-to-batch (Fig. 3).
Fig. 3: Batch-to-batch reproducibility using jetPEI®. For each lot, HeLa cells were transfected in triplicate in the presence of serum using the standard protocol for a 24-well plate.
Efficient in a wide range of cell types
jetPEI® successfully delivers genes to various adherent and non-adherent cell lines, as well as primary cells (Table 1). Over 550 publications using jetPEI® can be found in the Polyplus-transfection Database. In addition, our online Database gives specific transfection conditions for over 400 cell lines and primary cells.
Table 1: Some common cell lines and primary cells successfully transfected using jetPEI®.
Superior transfection results
jetPEI® was compared to several other popular transfection reagents (Fig. 4). jetPEI® was found to offer the best performance: high efficiency and low variability (small standard deviation).
Fig. 4: Transfection efficiency of a series of commercial reagents. HeLa cells were transfected in 24-well plates in the presence of 10% serum, using 1 µg pCMV-luciferase according to the manufacturers’ protocols. Luciferase expression was measured 24 h after transfection.
FAQ
If you have any questions regarding jetPEI®, please visit our dedicated Frequently asked questions or contact us.
Applications
Our jetPEI® reagent is perfectly well suited for plasmid DNA transfection, especially for High-Troughput Screening (HTS) application.
Quality
Every batch of jetPEI® is tested in-house by DNA transfection of HeLa cells. Transfection with a firefly Luciferase gene under the control of CMV promoter gives at least 109 RLU (relative light unit)/mg of protein. The value for each batch is indicated on the Certificate of Analysis.
Protocol
In order to download a product protocol or a certificate of analysis, please create an account on Polyplus-transfection® Portal.
Why would you need to create an account?
In this personal area you will have access to:
- Product Protocols
- Certificates of Analysis
- Exclusive webinars/articles
- And surprise features!
Other files
Related blog posts
Bibliography
Cell Line | in vitro in vivo | Delivered Molecule | Reagent | Results & Citations | |
---|---|---|---|---|---|
Human bone marrow-derived dendritic cells | in vitro | DNA | jetPEI, jetPEI-FluoF | Ciesielski, M. J. et al. (2006) Cancer Immunol Immunother 55, 1491-503 Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas | More details |
MCF7 | in vitro | DNA | jetPEI | Sendon-Lago, J. et al. (2014) Breast Cancer Res , Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13 | More details |
HEK-293 | in vitro | DNA | jetPEI | Kamal, M. et al. (2015) J Biol Chem 290, 11537-46 Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers | More details |
HL-1, Mouse neonatal cardiomyocytes, Mouse primary peritoneal macrophages | in vitro | DNA | jetPEI | Cuenca, J. et al. (2007) Am J Pathol 171, 820-8 Selective impairment of nuclear factor-kappaB-dependent gene transcription in adult cardiomyocytes: relevance for the regulation of the inflammatory response in the heart | More details |
HOS, Saos-2 | in vitro | DNA | jetPEI | Lamora, A. et al. (2014) Clin Cancer Res 20, 5097-112 Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma | More details |
COS-1 | in vitro | DNA | jetPEI | Kazi, J. U. et al. (2012) J Biol Chem 287, 36509-17 Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3 | More details |
HEK-293T | in vitro | DNA | jetPEI | de Chassey, B. et al. (2007) Mol Cell Proteomics 6, 451-459 An Antiproliferative Genetic Screening Identifies a Peptide Aptamer That Targets Calcineurin and Up-regulates Its Activity | More details |
HEK-293T | in vitro | shRNA and DNA cotransfection | jetPEI | Su, Y. F. et al. (2014) PLoS One 9, e91644 The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients | More details |
JB6, MCF7 | in vitro | DNA | jetPEI | Kim, G. et al. (2013) Carcinogenesis 34, 341-50 Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity | More details |
HeLa, MEF | in vitro | DNA | jetPEI | Didiot, M. C. et al. (2008) Nucleic Acids Res 36, 4902-12 The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer | More details |